Inflammatory bowel disease patients undergoing total hip arthroplasty have higher odds of implant-related complications

Abstract

Purpose:

This study evaluates whether IBD patients are at increased risk of implant-related complications after THA.

Materials and methods:

A retrospective study from 01 January 2010 to 31 October 31 2020 using an administrative claims database was performed. IBD patients undergoing THA (n = 11,025), without corticosteroid treatment, were propensity score matched to controls in a 1:5 ratio (n = 55,121) based on age, sex, and the Charlson Comorbidity Index (CCI). Outcomes evaluated included periprosthetic fracture, aseptic loosening, prosthetic joint infection, and THA revision within 2 years of index procedure. Chi-square analyses were used to compare the matched cohorts. The association of IBD and implant-related complications was evaluated using logistical regression to calculate odds ratios (ORs), 95% confidence intervals (95% CIs), and p-values. A p-value < 0.001 was used as the significance threshold.

Results:

Patients with IBD had a greater incidence and odds of total implant complications (7.03% vs. 3.98%; OR 1.76; p < 0.001) compared with matched controls. IBD patients had significantly higher incidence and odds of developing periprosthetic fracture (0.50% vs. 0.20%; OR 2.46; p < 0.001), THA revisions (2.21% vs. 1.17%; OR 1.91; p < 0.001), aseptic loosening (1.45% vs. 0.84%; OR 1.75; p < 0.001), and prosthetic joint infection (2.87% vs. 1.77%; OR 1.64; p < 0.001).

Conclusions:

Patients with IBD who underwent primary THA had a significantly higher risk of implant-related complications compared to matched controls. Providers should use this study to appropriately assess post-complication risk factors for their patients with IBD.

Keywords

Aseptic loosening inflammatory bowel disease periprosthetic fracture postoperative complications prosthetic joint infection total hip arthroplasty

Get full access to this article

View all access options for this article.

References

Rubin

Shaker

Levin

. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol 2012; 3: 107.

Kappelman

Rifas-Shiman

Kleinman

, et al. The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007; 5: 1424–1429.

Loftus

. The burden of inflammatory bowel disease in the United States: a moving target? Clin Gastroenterol Hepatol 2007; 5: 1383–1384.

Rogler

Singh

Kavanaugh

, et al. Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology 2021; 161: 1118–1132.

Moran

Wessman

Rolfson

, et al. The risk of revision following total hip arthroplasty in patients with inflammatory bowel disease, a registry based study. PLoS One 2021; 16: e0257310.

Kapadia

Issa

Nagrare

, et al. Higher revision and complication rates following total hip arthroplasty in patients with inflammatory bowel disease. J Arthroplasty 2014; 29: 596–600.

Chisari

D’Mello

Sherman

, et al. Inflammatory bowel diseases increase the risk of periprosthetic joint infection. J Bone Joint Surg Am 2022; 104: 160–165.

Malahias

Cohen

, et al. Prior knee arthroscopy is associated with increased risk of revision after total knee arthroplasty. J Arthroplasty 2020; 35: 100–104.

Vakharia

Bozic

, et al. Clinical and administrative databases used in lower extremity arthroplasty research. J Arthroplasty 2021; 36: 3608–3615.

10.

Browne

Cancienne

Novicoff

, et al. Removal of an infected hip arthroplasty is a high-risk surgery: putting morbidity into context with other major nonorthopedic operations. J Arthroplasty 2017; 32: 2834–2841.

11.

Hinton

Ryan

, et al. Current trends in revision hip arthroplasty: indications and types of components revised. J Arthroplasty 2022; 37(Suppl.): S611–S615.e7.

12.

Sambrook

Jones

. Corticosteroid osteoporosis. Rheumatology 1995; 34: 8–12.

13.

Lukert

. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112: 352–364.

14.

Klein

Arnaud

Gallagher

, et al. Intestinal calcium absorption in exogenous hypercortisonism. J Clin Invest 1977; 60: 253–259.

15.

Maier

Kolbow

Lazovic

, et al. The importance of bone mineral density in hip arthroplasty: results of a survey asking orthopaedic surgeons about their opinions and attitudes concerning osteoporosis and hip arthroplasty. Adv Ortho 2016; 2016: 8079354.

16.

Wooley

Schwarz

. Aseptic loosening. Gene Ther 2004; 11: 402–407.

17.

D’Haens

Baert

van Assche

, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn’s disease: an open randomised trial. Lancet 2008; 371: 660–667.

18.

Alverdy

Hyman

Gilbert

. Re-examining causes of surgical site infections following elective surgery in the era of asepsis. Lancet Infect Dis 2020; 20: e38–e43.

19.

Masters

Trombetta

de Mesy Bentley

, et al. Evolving concepts in bone infection: redefining “biofilm”, “acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy”. Bone Res 2019; 7: 20.

20.

Thwaites

Gant

. Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus? Nat Rev Microbiol 2011; 9: 215–222.

21.

Cancienne

Dempsey

Holzgrefe

, et al. Is hepatitis C infection associated with a higher risk of complications after total shoulder arthroplasty? Clin Orthop Relat Res 2016; 474: 2664–2669.

22.

Nelson

Polansky

Vakharia

, et al. Fibromyalgia increases 90-day complications and cost following primary total hip arthroplasty. Ann Jt 2018; 3: 71.

23.

Shen

Bovonratwet

, et al. Etiology and complications of early aseptic revision total hip arthroplasty within 90 days. J Arthroplasty 2021; 36: 1734–1739.

24.

Sinclair

Klika

Jin

, et al. The impact of surgeon variability on patient-reported outcomes in total hip arthroplasty. J Arthroplasty 2022; 37(Suppl.): S479–S487.e1.

25.

Voyvodic

Khan

Lam

, et al. Crohn’s disease is associated with longer in-hospital lengths of stay and higher rates of complications and costs after primary total hip arthroplasty. J Arthroplasty 2021; 36: 2110–2115.

26.

Traven

Chiaramonti

Barfield

, et al. Fewer complications following revision hip and knee arthroplasty in patients with normal vitamin D levels. J Arthroplasty 2017; 32(Suppl.): S193–S196.